Thromboembolic disease and immunotherapy in lung cancer

dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorFernandez Garay, D.
dc.contributor.authorBlaya Boluda, N.
dc.contributor.authorRubio Perez, J.
dc.contributor.authorOrtega Moran, L.
dc.contributor.authorBrenes Castro, J.
dc.contributor.authorLage, Y.
dc.contributor.authorCacho Lavin, D.
dc.contributor.authorGuirao Rubio, C.
dc.contributor.authorBosque Moreno, J.
dc.contributor.authorMartin Fernandez de Soignie, A. M.
dc.contributor.authorLobo de Mena, M.
dc.contributor.authorObispo Portero, B.
dc.contributor.authorRosa Garrido, M. C.
dc.contributor.authorFont Puig, C.
dc.contributor.authorMunoz Martin, A.
dc.contributor.authorSanchez Canovas, M.
dc.contributor.authoraffiliation[Fernandez Garay, D.] Univ Jaen, Dept Med Oncol, Jaen, Spain
dc.contributor.authoraffiliation[Blaya Boluda, N.] Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain
dc.contributor.authoraffiliation[Sanchez Canovas, M.] Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain
dc.contributor.authoraffiliation[Rubio Perez, J.] Fdn Jimenez Diaz, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Ortega Moran, L.] Univ Gregorio Maranon, Med Oncol, Fdn Invest Biomed, Gen Hosp, Madrid, Spain
dc.contributor.authoraffiliation[Munoz Martin, A.] Univ Gregorio Maranon, Med Oncol, Fdn Invest Biomed, Gen Hosp, Madrid, Spain
dc.contributor.authoraffiliation[Brenes Castro, J.] Inst Catalan Oncol Hosp, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Lage, Y.] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Cacho Lavin, D.] Hosp Univ Marques de Valdecilla, Med Oncol, Santander, Spain
dc.contributor.authoraffiliation[Guirao Rubio, C.] Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain
dc.contributor.authoraffiliation[Bosque Moreno, J.] Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain
dc.contributor.authoraffiliation[Martin Fernandez de Soignie, A. M.] Hosp Univ Fuenlabrada, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Lobo de Mena, M.] Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Obispo Portero, B.] Hosp Univ Infanta Leonor, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Rosa Garrido, M. C.] Hosp Univ Jaen, Res Unit, Biostat, Jaen, Spain
dc.contributor.authoraffiliation[Font Puig, C.] Hosp Clin Barcelona, Internal Med, Barcelona, Spain
dc.date.accessioned2025-01-07T14:40:31Z
dc.date.available2025-01-07T14:40:31Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1663
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.1663
dc.identifier.urihttps://hdl.handle.net/10668/26578
dc.identifier.wosID700527703236
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario de Jaén
dc.page.numberS1182-S1183
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleThromboembolic disease and immunotherapy in lung cancer
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files